FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matteo Bellone

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Lymphocyte Activation

Concepts & Ideas

Molecular Sequence Data

Disorders

Genes & Molecular Sequences

Amino Acid Sequences

Co-author Network

Publications

TOP 3
Arianna Calcinotto; Rossella Canese; Agata Cova; Angelo De Milito; Stefano Fais; Paola Filipazzi; Luca Generoso; Matteo Grioni; Veronica Huber; Manuela Iero; Elena Jachetti; Giorgio Parmiani; Alessia Ricupito; Matteo Bellone; Martina Borghi; Monica Rossetti; mario santinami; Licia Rivoltini
Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.
Nicolò Rigamonti; Matteo Bellone
Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy.
Arianna Calcinotto; Angelo Corti; Flavio Curnis; Matteo Grioni; Elena Jachetti; Anna Mondino; Giorgio Parmiani; Matteo Bellone
Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matteo Bellone (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Arianna Calcinotto; Rossella Canese; Agata Cova; Angelo De Milito; Stefano Fais; Paola Filipazzi; Luca Generoso; Matteo Grioni; Veronica Huber; Manuela Iero; Elena Jachetti; Giorgio Parmiani; Alessia Ricupito; Matteo Bellone; Martina Borghi; Monica Rossetti; mario santinami; Licia Rivoltini
Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.
Cancer research 2012;72(11):2746-56.
2012: Nicolò Rigamonti; Matteo Bellone
Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy.
Cancer immunology, immunotherapy : CII 2012;61(4):453-68.
2012: Arianna Calcinotto; Angelo Corti; Flavio Curnis; Matteo Grioni; Elena Jachetti; Anna Mondino; Giorgio Parmiani; Matteo Bellone
Targeting TNF-α to neoangiogenic vessels enhances lymphocyte infiltration in tumors and increases the therapeutic potential of immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(6):2687-94.
2011: Nicolò Rigamonti; Giusy Capuano; Alessia Ricupito; Elena Jachetti; Matteo Grioni; Luca Generoso; Massimo Freschi; Matteo Bellone
Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(5):1012-23.
2011: Teresa Manzo; Rodrigo Hess Michelini; Veronica Basso; Alessia Ricupito; Jian-Guo Chai; Elizabeth Simpson; Matteo Bellone; Anna Mondino
Concurrent allorecognition has a limited impact on posttransplant vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2011;186(3):1361-8.
2010: Rodrigo Hess Michelini; Massimo Freschi; Teresa Manzo; Elena Jachetti; Elena Degl'Innocenti; Matteo Grioni; Veronica Basso; Chiara Bonini; Elizabeth Simpson; Anna Mondino; Matteo Bellone
Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumors.
Cancer research 2010;70(9):3505-14.
2010: Marianna Esposito; Ruffini Francesca; Matteo Bellone; Nicola Gagliani; Manuela Battaglia; Gianvito Martino; Roberto Furlan
Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation.
Journal of neuroimmunology 2010;220(1-2):52-63.
2010: Matteo Bellone; Monica Ceccon; Matteo Grioni; Elena Jachetti; Arianna Calcinotto; Anna Napolitano; Massimo Freschi; Giulia Casorati; Paolo Dellabona
iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.
PloS one 2010;5(1):e8646.
2009: Sara Belloli; Elena Jachetti; Rosa M Moresco; Maria Picchio; Marzia Lecchi; Silvia Valtorta; Massimo Freschi; Rodrigo Hess Michelini; Matteo Bellone; Ferruccio Fazio
Characterization of preclinical models of prostate cancer using PET-based molecular imaging.
European journal of nuclear medicine and molecular imaging 2009;36(8):1245-55.
2009: Giusy Capuano; Nicolò Rigamonti; Matteo Grioni; Massimo Freschi; Matteo Bellone
Modulators of arginine metabolism support cancer immunosurveillance.
BMC immunology 2009;10():1.
2008: Anna Maria Gasparri; Elena Jachetti; Barbara Colombo; Angelina Sacchi; Flavio Curnis; Gian-Paolo Rizzardi; Catia Traversari; Matteo Bellone; Angelo Corti
Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma.
Molecular cancer therapeutics 2008;7(12):3859-66.
2008: Maria T S Bertilaccio; Matteo Grioni; Brent W Sutherland; Elena Degl'Innocenti; Massimo Freschi; Elena Jachetti; Norman M Greenberg; Angelo Corti; Matteo Bellone
Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer.
The Prostate 2008;68(10):1105-15.
2008: Matteo Bellone; Anna Mondino; Angelo Corti
Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer.
Trends in immunology 2008;29(5):235-41.
2008: Elena Degl'Innocenti; Matteo Grioni; Giusy Capuano; Elena Jachetti; Massimo Freschi; Maria T S Bertilaccio; Rodrigo Hess-Michelini; Claudio Doglioni; Matteo Bellone
Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cells.
Cancer research 2008;68(1):292-300.
2006: Andrea Boni; Giandomenica Iezzi; Elena Degl'Innocenti; Matteo Grioni; Elena Jachetti; Annalisa Camporeale; Matteo Bellone
Prolonged exposure of dendritic cells to maturation stimuli favors the induction of type-2 cytotoxic T lymphocytes.
European journal of immunology 2006;36(12):3157-66.
2006: Giandomenica Iezzi; Andrea Boni; Elena Degl'Innocenti; Matteo Grioni; Maria T S Bertilaccio; Matteo Bellone
Type 2 cytotoxic T lymphocytes modulate the activity of dendritic cells toward type 2 immune responses.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(4):2131-7.
2005: Sara Muraro; Attilio Bondanza; Matteo Bellone; Philip D Greenberg; Chiara Bonini
Molecular modification of idiotypes from B-cell lymphomas for expression in mature dendritic cells as a strategy to induce tumor-reactive CD4+ and CD8+ T-cell responses.
Blood 2005;105(9):3596-604.
2005: Anna Casati; Valérie S Zimmermann; Fabio Benigni; Maria T S Bertilaccio; Matteo Bellone; Anna Mondino
The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administration.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3317-25.
2005: Elena Degl'Innocenti; Matteo Grioni; Andrea Boni; Annalisa Camporeale; Maria T S Bertilaccio; Massimo Freschi; Antonella Monno; Cinzia Arcelloni; Norman M Greenberg; Matteo Bellone
Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization.
European journal of immunology 2005;35(1):66-75.
2004: Angelina Sacchi; Anna Gasparri; Flavio Curnis; Matteo Bellone; Angelo Corti
Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin.
Cancer research 2004;64(19):7150-5.
2004: Cristiana Perrotta; sestina Falcone; Annalisa Capobianco; Annalisa Camporeale; Clara Sciorati; Clara De Palma; Addolorata Pisconti; Patrizia Rovere-Querini; Matteo Bellone; angelo manfredi; Emilio Clementi
Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanoma.
Cancer research 2004;64(11):3767-71.
2004: Matteo Bellone; Annalisa Camporeale; Andrea Boni
Dendritic cell activation kinetics and cancer immunotherapy.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(5):2727-8.
2003: Annalisa Camporeale; Andrea Boni; Giandomenica Iezzi; Elena Degl'Innocenti; Matteo Grioni; Anna Mondino; Matteo Bellone
Critical impact of the kinetics of dendritic cells activation on the in vivo induction of tumor-specific T lymphocytes.
Cancer research 2003;63(13):3688-94.
2003: Samuele E Burastero; Silvia Galbiati; Antonia Vassallo; Maria Grazia Sabbadini; Matteo Bellone; Lucia Marchionni; Maddalena Smid; Elisabetta Ferrero; Augusto Ferrari; Maurizio Ferrari; Laura Cremonesi
Cellular microchimerism as a lifelong physiologic status in parous women: an immunologic basis for its amplification in patients with systemic sclerosis.
Arthritis and rheumatism 2003;48(4):1109-16.
2002: Franco Folli; Lucia Perego; Maurilio Ponzoni; A M Girardi; Emanuele Bosi; A J M Ferreri; Matteo Bellone; Maria Grazia Sabbadini; Aurelio Vicari; livio trusolino
Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma.
Annals of hematology 2002;81(10):597-602.
2002: Paola Castiglioni; Alfonso Martin-Fontecha; Gabriella Milan; Valentina Tomajer; Fulvio Magni; Jakob Michaelsson; Claudio Rugarli; Antonio Rosato; Matteo Bellone
Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cells.
Cancer research 2002;62(4):1116-22.
2001: Maria Grazia Sabbadini; Enrica Bozzolo; Elena Baldissera; Matteo Bellone
Takayasu's arteritis: therapeutic strategies.
Journal of nephrology 2001;14(6):525-31.
2000: Matteo Bellone
Apoptosis, cross-presentation, and the fate of the antigen specific immune response.
Apoptosis : an international journal on programmed cell death 2000;5(4):307-14.
2000: Matteo Bellone; Daniela Cantarella; P Castiglioni; Mariacristina Crosti; A Ronchetti; Monica Moro; MP Garancini; Giulia Casorati; Paolo Dellabona
Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(5):2651-6.
2000: L Ferrario; Matteo Bellone; Enrica Bozzolo; Elena Baldissera; Maria Grazia Sabbadini
Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A.
Rheumatology (Oxford, England) 2000;39(2):218-220.
2000: Enrica Bozzolo; Matteo Bellone; N Quaroni; C Voci; Maria Grazia Sabbadini
Thymoma associated with systemic lupus erythematosus and immunologic abnormalities.
Lupus 2000;9(2):151-4.
1999: Matteo Bellone; Giandomenica Iezzi; MA Imro; Maria Pia Protti
Cancer immunotherapy: synthetic and natural peptides in the balance.
Immunology today 1999;20(10):457-62.
1999: A Ronchetti; Giandomenica Iezzi; Mariacristina Crosti; MP Garancini; Maria Pia Protti; Matteo Bellone
Role of antigen-presenting cells in cross-priming of cytotoxic T lymphocytes by apoptotic cells.
Journal of leukocyte biology 1999;66(2):247-51.
1999: A Ronchetti; Patrizia Rovere-Querini; Giandomenica Iezzi; Giovanni Galati; S Heltai; Maria Pia Protti; MP Garancini; angelo manfredi; Claudio Rugarli; Matteo Bellone
Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(1):130-6.
1999: Monica Moro; Anna Gasparri; S Pagano; Matteo Bellone; P Tornaghi; F Veglia; Angelo Corti; Giulia Casorati; Paolo Dellabona
Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules.
Cancer research 1999;59(11):2650-6.
1999: MA Imro; Simona Manici; V Russo; Giuseppe Consogno; Matteo Bellone; Claudio Rugarli; Catia Traversari; Maria Pia Protti
Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s).
Cancer research 1999;59(10):2287-91.
1999: Simona Manici; Tiziana Sturniolo; MA Imro; Juergen Hammer; Francesco Sinigaglia; Christoph Noppen; Giulio Spagnoli; B Mazzi; Matteo Bellone; Paolo Dellabona; Maria Pia Protti
Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11.
The Journal of experimental medicine 1999;189(5):871-6.
1998: MA Imro; Paolo Dellabona; Simona Manici; S Heltai; Giuseppe Consogno; Matteo Bellone; Claudio Rugarli; Maria Pia Protti
Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro.
Human gene therapy 1998;9(9):1335-44.
1998: Maria Pia Protti; Matteo Bellone
Immunotherapy: natural versus synthetic peptides.
Immunology today 1998;19(2):98.
1997: Matteo Bellone; Giandomenica Iezzi; Patrizia Rovere-Querini; Giovanni Galati; A Ronchetti; Maria Pia Protti; Jean Davoust; Claudio Rugarli; angelo manfredi
Processing of engulfed apoptotic bodies yields T cell epitopes.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(11):5391-9.
1997: Giandomenica Iezzi; L Rivolta; A Ronchetti; Alfonso Martin-Fontecha; A Rosato; Maria Pia Protti; Maria Grazia Sabbadini; Matteo Bellone
The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.
Cancer research 1997;57(13):2564-8.
1997: Matteo Bellone; Giandomenica Iezzi; Alfonso Martin-Fontecha; L Rivolta; angelo manfredi; Maria Pia Protti; Massimo Freschi; Paolo Dellabona; Giulia Casorati; Claudio Rugarli
Rejection of a nonimmunogenic melanoma by vaccination with natural melanoma peptides on engineered antigen-presenting cells.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(2):783-9.
1996: A Martin-Fontecha; Federica Cavallo; Matteo Bellone; S Heltai; Giandomenica Iezzi; P Tornaghi; N Nabavi; Guido Forni; Paolo Dellabona; Giulia Casorati
Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors.
European journal of immunology 1996;26(8):1851-9.
1996: Matteo Bellone
Engineered APCs for tumor immunotherapy.
Immunology today 1996;17(4):198.
1996: Maria Pia Protti; MA Imro; angelo manfredi; Giuseppe Consogno; S Heltai; Cinzia Arcelloni; Matteo Bellone; Paolo Dellabona; Giulia Casorati; Claudio Rugarli
Particulate naturally processed peptides prime a cytotoxic response against human melanoma in vitro.
Cancer research 1996;56(6):1210-3.
1996: Giandomenica Iezzi; Maria Pia Protti; Claudio Rugarli; Matteo Bellone
B7.1 expression on tumor cells circumvents the need of professional antigen presentation for in vitro propagation of cytotoxic T cell lines.
Cancer research 1996;56(1):11-5.
1995: Peter I Karachunski; Norma Ostlie; Matteo Bellone; Anthony Infante; Bianca M Conti-Fine
Mechanisms by which the I-ABM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice.
Scandinavian journal of immunology 1995;42(2):215-25.
1995: Federica Cavallo; A Martin-Fontecha; Matteo Bellone; S Heltai; E Gatti; P Tornaghi; Massimo Freschi; Guido Forni; Paolo Dellabona; Giulia Casorati
Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response.
European journal of immunology 1995;25(5):1154-62.
1995: Matteo Bellone; Peter I Karachunski; Norma Ostlie; S Lei; Bianca M Conti-Fine
Clustering of B and T epitopes within short sequence regions of the nicotinic acetylcholine receptor.
Scandinavian journal of immunology 1995;41(2):135-40.
1994: Matteo Bellone; Giandomenica Iezzi; angelo manfredi; Maria Pia Protti; Paolo Dellabona; Giulia Casorati; Claudio Rugarli
In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.
European journal of immunology 1994;24(11):2691-8.
1994: Maria Pia Protti; S Heltai; Matteo Bellone; M Ferrarini; angelo manfredi; Claudio Rugarli
Constitutive expression of the heat shock protein 72 kDa in human melanoma cells.
Cancer letters 1994;85(2):211-6.
1994: Peter I Karachunski; Norma Ostlie; B M Conti-Tronconi; Matteo Bellone
Residues within the alpha subunit sequence 304-322 of muscle acetylcholine receptor forming autoimmune CD4+ epitopes in BALB/c mice.
Immunology 1994;82(1):22-7.
1994: Matteo Bellone; Peter I Karachunski; Norma Ostlie; S Lei; B M Conti-Tronconi
Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes.
European journal of immunology 1994;24(4):799-804.
1993: Matteo Bellone; Norma Ostlie; Peter I Karachunski; angelo manfredi; B M Conti-Tronconi
Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(2):1025-38.
1993: Maria Pia Protti; angelo manfredi; R M Horton; Matteo Bellone; B M Conti-Tronconi
Myasthenia gravis: recognition of a human autoantigen at the molecular level.
Immunology today 1993;14(7):363-8.
1992: angelo manfredi; Maria Pia Protti; Matteo Bellone; L Moiola; B M Conti-Tronconi
Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
The Journal of laboratory and clinical medicine 1992;120(1):13-21.
1992: Matteo Bellone; Norma Ostlie; S Lei; angelo manfredi; B M Conti-Tronconi
T helper function of CD4+ cells specific for defined epitopes on the acetylcholine receptor in congenic mouse strains.
Journal of autoimmunity 1992;5(1):27-46.
1991: Matteo Bellone; Norma Ostlie; S Lei; B M Conti-Tronconi
Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
European journal of immunology 1991;21(10):2303-10.
1991: Matteo Bellone; Norma Ostlie; S J Lei; X D Wu; B M Conti-Tronconi
The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(5):1484-91.
1991: angelo manfredi; Matteo Bellone; Maria Pia Protti; B M Conti-Tronconi
Molecular mimicry among human autoantigens.
Immunology today 1991;12(1):46-7.
1989: Matteo Bellone; F Tang; R Milius; B M Conti-Tronconi
The main immunogenic region of the nicotinic acetylcholine receptor. Identification of amino acid residues interacting with different antibodies.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(11):3568-79.
1989: Antonio Secchi; F Crosti; L Bonisolli; D Pavoni; F Capra; P Navone; Antonio E Pontiroli; Matteo Bellone; Claudio Rugarli; Guido Pozza
Impairment of lymphocyte suppressive system in recent onset insulin-dependent diabetes mellitus. Correlation with blood glucose and serum insulin levels.
Acta diabetologica latina 1989;26(3):257-63.
1987: G Ciboddo; F Crosti; G Di Lucca; Matteo Bellone
Cimetidine treatment in hyper-IgM hypogammaglobulinemia.
JAMA : the journal of the American Medical Association 1987;258(14):1892.
1987: D Pavoni; F Crosti; G F Ciboddo; M G Sabbadini; V Baldini; P Navone; Matteo Bellone; Claudio Rugarli
Thymopentine treatment improves clinical and immunological functions in aged subjects with chronic bronchitis.
Bollettino dell'Istituto sieroterapico milanese 1987;66(4):308-15.